Blueprint Medicines is a brand that is committed to advancing precision therapies to help patients live longer, healthier lives. Their approach combines expertise in protein kinases with a strong focus on discovery and effective execution. With a diverse and expanding portfolio of research programs, they are developing multiple investigational medicines for genomically defined cancers and rare diseases.

Blueprint Medicines aims to leverage the potential of protein kinases, which play a critical role in controlling biochemical pathways and are involved in various aspects of tumor biology. They are driven by a passion for innovation and strive to connect the worlds of drug discovery, clinical development, and commercialization to deliver potent, selective medicines. By focusing on the genomic drivers of disease, they aim to identify the individuals most likely to benefit from their therapies, streamline the clinical development process, and ultimately provide transformative treatments to patients